ES2180703T3 - Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante. - Google Patents

Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante.

Info

Publication number
ES2180703T3
ES2180703T3 ES96303930T ES96303930T ES2180703T3 ES 2180703 T3 ES2180703 T3 ES 2180703T3 ES 96303930 T ES96303930 T ES 96303930T ES 96303930 T ES96303930 T ES 96303930T ES 2180703 T3 ES2180703 T3 ES 2180703T3
Authority
ES
Spain
Prior art keywords
scallene
scalan
mammals
phospholipide
tensioactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96303930T
Other languages
English (en)
Other versions
ES2180703T5 (es
Inventor
Richard Norman Hjorth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23825442&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2180703(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of ES2180703T3 publication Critical patent/ES2180703T3/es
Publication of ES2180703T5 publication Critical patent/ES2180703T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

ESTA INVENCION DESCRIBE COMPOSICIONES DE VACUNAS PARA MAMIFEROS QUE CONTIENEN UNA CANTIDAD EFICAZ DE UN ADYUVANTE COMPUESTO POR ESCUALENO O ESCUALANO, UNO O MAS FOSFOLIPIDOS Y UN SURFACTANTE. OPCIONALMENTE, ESTAS COMPOSICIONES PUEDEN CONTENER SALES DE ALUMINIO Y UNO O MAS TAMPONES FARMACEUTICAMENTE ACEPTABLES.
ES96303930T 1995-06-02 1996-05-31 Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante. Expired - Lifetime ES2180703T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/459,602 US5690942A (en) 1995-06-02 1995-06-02 Adjuvants for viral vaccines
US459602 1995-06-02

Publications (2)

Publication Number Publication Date
ES2180703T3 true ES2180703T3 (es) 2003-02-16
ES2180703T5 ES2180703T5 (es) 2007-04-01

Family

ID=23825442

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96303930T Expired - Lifetime ES2180703T5 (es) 1995-06-02 1996-05-31 Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante.

Country Status (13)

Country Link
US (1) US5690942A (es)
EP (1) EP0745388B2 (es)
JP (1) JP4249807B2 (es)
KR (1) KR970000249A (es)
AT (1) ATE222504T1 (es)
AU (1) AU710499B2 (es)
CA (1) CA2177667C (es)
DE (1) DE69623072T3 (es)
DK (1) DK0745388T4 (es)
ES (1) ES2180703T5 (es)
HU (1) HUP9601462A2 (es)
NZ (1) NZ286700A (es)
PT (1) PT745388E (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
NZ501128A (en) * 1999-01-29 2001-12-21 Pfizer Prod Inc Erysipelothrix rhusiopathiae antigens and vaccine compositions
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
AT407958B (de) * 1999-02-11 2001-07-25 Immuno Ag Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
US7632929B2 (en) * 2000-04-20 2009-12-15 The Board Of Trustees Of The University Of Arkansas Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
US6676958B2 (en) 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
PT1613346E (pt) * 2003-04-04 2013-01-29 Pah Usa 15 Llc Emulsões óleo-em-água microfluidificadas e composições de vacinas
JP5393978B2 (ja) 2004-04-05 2014-01-22 ゾエティス・ピー・エルエルシー マイクロ流動化された水中油型乳剤及びワクチン組成物
JP2007532666A (ja) * 2004-04-14 2007-11-15 アヴィリッド インコーポレーテッド ウイルス核酸を対象とした修飾ヌクレアーゼを用いた組成物及びウイルス性疾患の予防並びに治療方法
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
US8853146B2 (en) * 2007-04-20 2014-10-07 The Board Of Trustees Of The University Of Arkansas Hapten compounds and compositions and uses thereof
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
GB0801122D0 (en) * 2008-01-22 2008-02-27 Avecia Biolog Ltd Vaccine composition
CA2738621C (en) 2008-10-02 2017-01-31 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
GB0917887D0 (en) * 2009-10-13 2009-11-25 Milan Guy D Temperature sensitive packaging closures
US9023353B2 (en) 2013-03-13 2015-05-05 The Board Of Trustees Of The University Of Arkansas Anti-(+)—methamphetamine monoclonal antibodies
CN104208029B (zh) * 2013-05-30 2017-06-06 上海医药工业研究院 一种鼻用疫苗组合物粉体制剂及其制备方法
US10653766B2 (en) 2014-03-12 2020-05-19 Bavarian Nordic A/S Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1163470A (en) * 1967-11-13 1969-09-04 Cecil Arthur Clark Improvements in or relating to Adjuvant Vaccines
US4466957A (en) * 1982-02-25 1984-08-21 American Home Products Corporation Vaccine adjuvants
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
FR2649013B1 (fr) † 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
FR2649012B1 (fr) † 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
WO1993024147A1 (en) † 1992-05-29 1993-12-09 Smithkline Beecham Corporation Lecithin adjuvanted modified live virus vaccines
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
DK0745388T3 (da) 2002-12-02
DE69623072D1 (de) 2002-09-26
HUP9601462A2 (en) 1997-03-28
NZ286700A (en) 1997-10-24
EP0745388A1 (en) 1996-12-04
AU710499B2 (en) 1999-09-23
HU9601462D0 (en) 1996-07-29
DE69623072T2 (de) 2002-12-19
CA2177667C (en) 2008-06-17
KR970000249A (ko) 1997-01-21
EP0745388B1 (en) 2002-08-21
ES2180703T5 (es) 2007-04-01
JPH08325162A (ja) 1996-12-10
ATE222504T1 (de) 2002-09-15
DK0745388T4 (da) 2007-01-08
DE69623072T3 (de) 2007-03-29
US5690942A (en) 1997-11-25
CA2177667A1 (en) 1996-12-03
JP4249807B2 (ja) 2009-04-08
PT745388E (pt) 2002-11-29
EP0745388B2 (en) 2006-08-30
AU5457496A (en) 1996-12-12

Similar Documents

Publication Publication Date Title
ES2180703T3 (es) Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante.
HN2002000153A (es) Formulaciones autoemulsionantes de inhibidores de la proteina de transferencia de colesteril ester.
UY27740A1 (es) Nuevos compuestos
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
UY26776A1 (es) Inhibidores de 3-hidroxi-3-metilglutaril-coenzima a reductasa y métodos.
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
CR9609A (es) Formulaciones de una sal de bupropion de liberacion modificada
GT199700015A (es) Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion.
CL2009001279A1 (es) Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03).
PA8521701A1 (es) Derivados de pirazol
PA8518801A1 (es) Derivados de 2-aminocarbonil-9h-purina
SV2004001459A (es) 2- (piridin-2-ilamino) -pirido [2,3-d]pirimidin-7-onas ref. pc20501
GT200000096A (es) Derivados de purina.
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
PA8567001A1 (es) Composicion de ziprasidona y controles sinteticos
ECSP088296A (es) Compuestos terapéuticos
ES2172024T3 (es) Composicion para el tratamiento del cabello que contiene un complejo de aminoacido-metal.
DE60114635D1 (de) Pharmazeutische formulierungen
DE69634024D1 (de) Adjuvans für vitale Impfstoffe
PA8426801A1 (es) Composiciones farmaceuticas para el tratamiento de la rinitis.
BR0309691A (pt) Formulação de ibandronato em alta dose
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
UY27461A1 (es) Formas pseudopolimorficas de cardevilol.